IJR News — today's news from every side
+84 Elena Vasquez Halzen's IceCube project finally confirmed high-energy neutrinos from space, and that breakthrough earns the prize.+60 Maya Lindstrom It is surprising they announced a 2026 winner this early, but his record with high-energy astrophysics stands out.
+266 Rachel Meyers Optogenetics could finally help us understand and treat brain disorders at the cellular level.Dana Whitfield The AG settlement cleared the way but these giant combinations always end up cutting jobs at the networks.+2 Maya Lindstrom Free signup for creators makes sense if they want real profiles, though the paid side for brands will decide if it lasts.
Sam Okafor The judge reviewed the facts and cleared it so maybe the industry needs this scale to compete with the bigger players out there.+24 Sam Okafor UEFA has no business filing court papers to smear Infantino right before the vote.+25 Sam Okafor States got some concessions here yet these media giants keep consolidating anyway which rarely helps prices or options.+6 Tom Gallagher Lilly is betting big on InnoCare's platform with those billions in milestones, but execution will decide if it pays off.+8 Marcus Bell With 461 million already raised plus AbbVie ties, this IPO could help Iambic advance those early trials effectively.+6 Nicole Hardy The $111 billion figure alone shows why regulators need to stand firm. Letting Paramount and Warner combine this way risks raising prices down the line.+14 Chris Dalton Testing these tools on specific workflows first makes sense before claiming big productivity gains.Dr. David Crean Book Guides Biopharma Leaders on Commercialization x/david-crean — Sep 18, 2026 A new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC. +5 Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.+3 Sam Okafor Ex-Google founders probably bring real expertise but this valuation surge on unconfirmed terms makes me question how sustainable the growth can be.